GSK-1070916A
Formula : C30-H33-N7-O
CAS :
942918-07-2
An antineoplastic agent with aurora B/C kinase inhibitory activity.
GSK-1268992
Formula : C21-H23-N7-O3-S
CAS :
1414375-49-7
GSK-1268997
Formula : C21-H23-N7-O3-S
CAS :
1414375-50-0
GSK-1292263 hydrochloride
Formula : C23-H28-N4-O4-S.Cl-H
CAS :
1032824-54-6
GSK-1482160
Formula : C14-H14-Cl-F3-N2-O2
CAS :
1001389-72-5
GSK-1521498
Formula :
CAS :
1007573-18-3
A mu-opioid receptor inverse agonist.
GSK-163090
Formula :
CAS :
844903-58-8
Antagonist of 5-HT1A, 5-HT1B, and 5-HT1D receptors.
GSK-183390
Formula : C27-H33-N3-O4
CAS :
852814-21-2
GSK-1838705A
Formula : C27-H27-F-N8-O3
CAS :
1186659-59-5
GSK-2018682
Formula : C22-H21-Cl-N4-O4
CAS :
1034688-30-6
A sphingosine-1-phosphate receptor modulator.
GSK-215083 C-11
Formula :
CAS :
887923-36-6
A PET radioligand for 5-HT6 receptor.
GSK-2239633
Formula : C24-H25-Cl-N4-O5-S2
CAS :
1240516-71-5
UNII-07ODS257BP
GSK-2239633A
GSK-2239633
GSK 2239633A
Propanamide| N-((3-((3-(((5-chloro-2-thienyl)sulfonyl)amino)-4-methoxy-1H-indazol-1-yl)methyl)phenyl)methyl)-2-hydroxy-2-methyl-
N-((3-((3-((5-Chloro-2-thienyl)sulfonylamino)-4-methoxy-indazol-1-yl)methyl)phenyl)methyl)-2-hydroxy-2-methyl-propanamide